WALD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Waldencast PLC is not a good buy at this moment for a beginner investor with a long-term perspective. The stock is in a bearish technical trend, lacks strong positive catalysts, and has underwhelming financial performance. Analysts have lowered price targets, and there are no recent signals from Intellectia Proprietary Trading Signals to suggest a strong entry point.
The stock is in a bearish trend with MACD negatively expanding, RSI indicating oversold conditions at 11.749, and moving averages showing a bearish alignment (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.075 and 0.927, with resistance at 1.555 and 1.704.
The company has strong brands like Obagi and Milk, which analysts believe have growth potential. The upcoming Saypha injectables launch could provide future upside.
The company is in a transition period, with slower-than-expected growth, elevated costs related to an SEC investigation and strategic review, and underwhelming Q4 financial results. Analysts have significantly lowered price targets.
In Q1 2025, revenue remained flat at $65.44M YoY, net income was $0, EPS was -1.51, and gross margin was 69.91%. There is no growth in key financial metrics.
Analysts have lowered price targets significantly (e.g., from $4 to $2) and maintain mixed ratings, with some keeping a Buy rating and others a Market Perform rating. The consensus is that the company is undervalued but currently underperforming due to high costs and a transition period.
